Searchable abstracts of presentations at key conferences in endocrinology

ea0098c13 | Clinical – Chemo/SSA/Biologics | NANETS2023

Clinical characteristics and molecular profiling of patients with pancreatic mixed acinar-neuroendocrine carcinoma

Eslinger Cody , Seddighzadeh Bobak , Elsabbagh Zaid , Pai Rish , Hartley Chris , Starr Jason , Bekaii-Saab Tanios , Halfdanarson Thorvardur , Bassam Sonbol Mohamad

Background: Pancreatic acinar cell carcinoma (PACC) is a rare cancer, comprising less than 1% of all pancreatic cancers and often presents as a mixed malignancy with a neuroendocrine component. Limited data exists on its clinical and molecular characteristics. This retrospective study aims to provide additional insights to better understand and characterize the disease.Methods: Patients from the Mayo Clinic with pathology records denoting pancreatic acin...

ea0098o9 | Other | NANETS2023

Prevalence of clonal hematopoiesis (CH) in neuroendocrine tumor (NET) patients prior to lutetium 177 Dotatate (Lu177): A prospective study

Bassam Sonbol Mohamad , Kusne Yael , Lasho Terra , Elsabbagh Zaid , Mangaonkar Abhishek , Ahn Daniel , Eiring Rachel , Hobday Timothy , Starr Jason , Bekaii-Saab Tanios , Patnaik Mrinal , Halfdanarson Thorvardur

Background: Lu177 has shown efficacy in advanced NET with significant hematologic toxicity, including therapy-related myeloid neoplasm (t-MN). CH is defined by acquisition of somatic mutations in hematopoietic stem cells with potential for expansion over time. In this study, we aimed to assess the prevalence of CH in NET patients (pts) prior to Lu177 along with the incidence of cytopenia in NET pts treated with lu177 based on the CH status at baselineMet...